Silymarin therapy and improvement of cardiac outcome in patients with β-thalassemia major
Saved in:
Main Authors: | Hadi Darvishi Khezri (Author), Mehrnoush Kosaryan (Author), Ebrahim Salehifar (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential Effects of Silymarin and Its Flavonolignan Components in Patients with β-Thalassemia Major: A Comprehensive Review in 2015
by: Hadi Darvishi Khezri, et al.
Published: (2016) -
Treatment Status of Patients with Β-Thalassemia Major in Northern Iran: Thalassemia Registry System
by: Mehrnoush KOSARYAN, et al.
Published: (2019) -
Decrease of Hepatitis C Burden in Patients With Transfusion Dependent Beta Thalassemia Major, Thalassemia Research Center, 1995 - 2014
by: Mehrnoush Kosaryan, et al.
Published: (2015) -
Decrease of Hepatitis C Burden in Patients With Transfusion Dependent Beta Thalassemia Major, Thalassemia Research Center, 1995 - 2014
by: Mehrnoush Kosaryan, et al.
Published: (2015) -
In Vitro Hb Production in Β-thalassemia Patients Is Not a Predictor of Clinical Responsiveness to Hydroxyurea
by: Mohammad Reza MAHDAVI, et al.
Published: (2017)